Home/ Supplements/ Omega 3/ DHA Softgel Capsule

DHA Softgel Capsule

product on market Softgel Capsule Exeltis USA Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic acid is an omega-3 fatty acid supported by strong evidence for supporting fetal and neonatal brain development. Research indicates it plays a critical role in maintaining cognitive function and retinal health. The ingredient profile is associated with a high safety rating for general supplementation.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DHA Softgel Capsule
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel Capsule(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Dosage and administration: Before, during and after pregnancy, one caplet and one softgel capsule daily, or as directed by a physician.

See package insert for full prescribing information

Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.

Contains: Soy.

Formulation Notes

Indications and usage: Vitafol-OB+DHA is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.

Indications and usage: Vitafol-OB+DHA is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.

Vitafol-OB+DHA does not contain fish, fish oils, fish proteins or fish byproducts.

Prenatal Supplement with DHA Natural source DHA

Sugar, lactose, gluten and iodine free

Vitafol-OB+DHA (Daily Dose)

Smaller DHA Softgel

Additional Information

How supplied: Vitafol-OB+DHA is available as a light blue caplet debossed EV0079 and one amber-colored DHA softgel capsule. Available in box of unit-dose pack of 30 (5 child resistant blister cards of 6 caplets and 6 softgel capsules each) (0642-0076-30) and as professional samples (0642-0076-03).

Store at room temperature, approximately 15 Degrees - 30 Degrees C (59 Degrees - 86 Degrees F), avoid excessive heat and moisture.

Unit dose pack

0642-0076-30

Metadata

Product Details

UPC / SKU3 0642-0076-30 5
DSLD Entry Date2023-11-22
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID304794
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.